# FDA 483 - Deseret Laboratories, Inc. - March 23, 2018

Source: https://www.keypedia.com/records/483/deseret-laboratories-inc/0664a5c9-f23a-479c-9892-5fb3d023865a

> FDA 483 for Deseret Laboratories, Inc. on March 23, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Deseret Laboratories, Inc.
- Inspection Date: 2018-03-23
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Deseret Laboratories, Inc. in Saint George, UT, was inspected and received a Form 483 with four observations primarily concerning inadequate quality control and record-keeping practices. The firm failed to properly calibrate equipment, maintain complete batch production records, ensure adequate laboratory controls, and provide complete stability testing records for homeopathic drug products. These issues indicate significant deficiencies in their manufacturing and quality systems.

## Related Documents

- [483 - 2022-11-18](https://www.keypedia.com/records/483/deseret-laboratories-inc/61763b27-5a22-49d3-bd9c-5f759a516c70)

## Related Officers

- [Compliance Officer](https://www.keypedia.com/people/rumany-c-penn/021eb1e0-8de0-403f-9596-3e76624b2e5a)

Company: https://www.keypedia.com/companies/deseret-laboratories-inc/1a062a64-f1a3-4945-8952-d86c4035b3c2

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6